sb 203580 has been researched along with sodium salicylate in 5 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (sodium salicylate) | Trials (sodium salicylate) | Recent Studies (post-2010) (sodium salicylate) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 2,031 | 50 | 171 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alpert, D; Han, J; Schwenger, P; Vilcek, J | 1 |
| Hjelm, NM; Ho, CY; Lam, CW; Wong, CK; Zhang, JP | 1 |
| Alpert, D; Vilcek, J | 1 |
| Bradbury, CM; Gius, D; Horikoshi, N; Markovina, S; Rene, LM; Wei, SJ; Zoberi, I | 1 |
| Ip, WK; Lam, CW; Wong, CK; Zhang, JP | 1 |
5 other study(ies) available for sb 203580 and sodium salicylate
| Article | Year |
|---|---|
Cell stress and MKK6b-mediated p38 MAP kinase activation inhibit tumor necrosis factor-induced IkappaB phosphorylation and NF-kappaB activation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Calcium-Calmodulin-Dependent Protein Kinases; COS Cells; DNA-Binding Proteins; Drug Interactions; Enzyme Activation; HT29 Cells; Humans; I-kappa B Proteins; Imidazoles; Interleukin-1; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase 6; Mitogen-Activated Protein Kinases; NF-kappa B; NF-KappaB Inhibitor alpha; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Signal Transduction; Sodium Salicylate; Stress, Physiological; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1999 |
Sodium salicylate-induced apoptosis of human peripheral blood eosinophils is independent of the activation of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Blotting, Western; Calcium-Calmodulin-Dependent Protein Kinases; Dose-Response Relationship, Drug; Enzyme Inhibitors; Eosinophils; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinases; Oligonucleotides, Antisense; p38 Mitogen-Activated Protein Kinases; Pyridines; Sodium Salicylate; Time Factors | 2000 |
Inhibition of IkappaB kinase activity by sodium salicylate in vitro does not reflect its inhibitory mechanism in intact cells.
Topics: Animals; Calcium-Calmodulin-Dependent Protein Kinases; COS Cells; Humans; I-kappa B Proteins; Imidazoles; Interleukin-1; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Pyridines; Sodium Salicylate; Tumor Necrosis Factor-alpha | 2000 |
Indomethacin-induced radiosensitization and inhibition of ionizing radiation-induced NF-kappaB activation in HeLa cells occur via a mechanism involving p38 MAP kinase.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cell Nucleus; Cell Survival; DNA; Drug Interactions; Enzyme Activation; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; I-kappa B Proteins; Imidazoles; Indomethacin; Mitogen-Activated Protein Kinases; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Pyridines; Radiation Tolerance; Sodium Salicylate; Sulindac; Transfection | 2001 |
Activation of p38 mitogen-activated protein kinase and nuclear factor-kappaB in tumour necrosis factor-induced eotaxin release of human eosinophils.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Chemokine CCL11; Chemokines, CC; Chemotactic Factors, Eosinophil; Cysteine Proteinase Inhibitors; DNA-Binding Proteins; Enzyme Activation; Eosinophils; Gene Expression Profiling; Humans; I-kappa B Proteins; Imidazoles; Leupeptins; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; NF-kappa B; NF-KappaB Inhibitor alpha; p38 Mitogen-Activated Protein Kinases; Pyridines; Sodium Salicylate; Tumor Necrosis Factor-alpha | 2002 |